FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039867072> ?p ?o ?g. }

• W3039867072 abstract "Hyperactivation of RNA polymerase I (Pol I) transcription of ribosomal RNA (rRNA) genes (rDNA) is a key determinant of growth and proliferation and a consistent feature of cancer cells. We have demonstrated that inhibition of rDNA transcription by the Pol I transcription inhibitor CX-5461 selectively kills tumour cells in vivo. Moreover, the first-in human trial of CX-5461 has demonstrated CX-5461 is well-tolerated in patients and has single-agent anti-tumour activity in hematologic malignancies. However, the mechanisms underlying tumour cell sensitivity to CX-5461 remain unclear. Understanding these mechanisms is crucial for the development of predictive biomarkers of response that can be utilized for stratifying patients who may benefit from CX-5461. The rDNA repeats exist in four different and dynamic chromatin states: inactive rDNA can be either methylated silent or unmethylated pseudo-silent; while active rDNA repeats are described as either transcriptionally competent but non-transcribed or actively transcribed, depending on the level of rDNA promoter methylation, loading of the essential rDNA chromatin remodeler UBF and histone marks status. In addition, the number of rDNA repeats per human cell can reach hundreds of copies. Here, we tested the hypothesis that the number and/or chromatin status of the rDNA repeats, is a critical determinant of tumour cell sensitivity to Pol I therapy. We systematically examined a panel of ovarian cancer (OVCA) cell lines to identify rDNA chromatin associated biomarkers that might predict sensitivity to CX-5461. We demonstrated that an increased proportion of active to inactive rDNA repeats, independent of rDNA copy number, determines OVCA cell line sensitivity to CX-5461. Further, using zinc finger nuclease genome editing we identified that reducing rDNA copy number leads to an increase in the proportion of active rDNA repeats and confers sensitivity to CX-5461 but also induces genome-wide instability and sensitivity to DNA damage. We propose that the proportion of active to inactive rDNA repeats may serve as a biomarker to identify cancer patients who will benefit from CX-5461 therapy in future clinical trials. The data also reinforces the notion that rDNA instability is a threat to genomic integrity and cellular homeostasis." @default.
• W3039867072 created "2020-07-10" @default.
• W3039867072 creator A5006267199 @default.
• W3039867072 creator A5020209705 @default.
• W3039867072 creator A5035230144 @default.
• W3039867072 creator A5041530254 @default.
• W3039867072 creator A5056461677 @default.
• W3039867072 creator A5057342173 @default.
• W3039867072 creator A5060918113 @default.
• W3039867072 creator A5072624832 @default.
• W3039867072 creator A5078260365 @default.
• W3039867072 creator A5087921736 @default.
• W3039867072 date "2020-07-03" @default.
• W3039867072 modified "2023-10-18" @default.
• W3039867072 title "rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461" @default.
• W3039867072 cites W1970540591 @default.
• W3039867072 cites W1979170620 @default.
• W3039867072 cites W1985122162 @default.
• W3039867072 cites W1994863100 @default.
• W3039867072 cites W2000461912 @default.
• W3039867072 cites W2007170592 @default.
• W3039867072 cites W2012112380 @default.
• W3039867072 cites W2020805433 @default.
• W3039867072 cites W2025926531 @default.
• W3039867072 cites W2032949964 @default.
• W3039867072 cites W2033742799 @default.
• W3039867072 cites W2034164551 @default.
• W3039867072 cites W2037235549 @default.
• W3039867072 cites W2049039063 @default.
• W3039867072 cites W2049883153 @default.
• W3039867072 cites W2050915272 @default.
• W3039867072 cites W2062981254 @default.
• W3039867072 cites W2064604046 @default.
• W3039867072 cites W2069701493 @default.
• W3039867072 cites W2080531393 @default.
• W3039867072 cites W2103015871 @default.
• W3039867072 cites W2106657280 @default.
• W3039867072 cites W2112444085 @default.
• W3039867072 cites W2114591008 @default.
• W3039867072 cites W2119477283 @default.
• W3039867072 cites W2120728889 @default.
• W3039867072 cites W2123282517 @default.
• W3039867072 cites W2123355529 @default.
• W3039867072 cites W2129104457 @default.
• W3039867072 cites W2131823236 @default.
• W3039867072 cites W2137400049 @default.
• W3039867072 cites W2137887425 @default.
• W3039867072 cites W2140691184 @default.
• W3039867072 cites W2151161614 @default.
• W3039867072 cites W2151529426 @default.
• W3039867072 cites W2157144047 @default.
• W3039867072 cites W2165202907 @default.
• W3039867072 cites W2179539353 @default.
• W3039867072 cites W2280989837 @default.
• W3039867072 cites W2430410405 @default.
• W3039867072 cites W2470218763 @default.
• W3039867072 cites W2477532021 @default.
• W3039867072 cites W2561930609 @default.
• W3039867072 cites W2578423810 @default.
• W3039867072 cites W2588267243 @default.
• W3039867072 cites W2593857065 @default.
• W3039867072 cites W2623793810 @default.
• W3039867072 cites W2694636033 @default.
• W3039867072 cites W2734388176 @default.
• W3039867072 cites W2752006971 @default.
• W3039867072 cites W2773619385 @default.
• W3039867072 cites W2800556562 @default.
• W3039867072 cites W2904964655 @default.
• W3039867072 cites W2907138462 @default.
• W3039867072 cites W2908528290 @default.
• W3039867072 cites W2908882997 @default.
• W3039867072 cites W2921552970 @default.
• W3039867072 cites W2941193973 @default.
• W3039867072 cites W2944290286 @default.
• W3039867072 cites W2945629440 @default.
• W3039867072 cites W2965198877 @default.
• W3039867072 cites W2988180713 @default.
• W3039867072 cites W2990248786 @default.
• W3039867072 cites W3004754093 @default.
• W3039867072 cites W3030525997 @default.
• W3039867072 doi "https://doi.org/10.3389/fcell.2020.00568" @default.
• W3039867072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7349920" @default.
• W3039867072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32719798" @default.
• W3039867072 hasPublicationYear "2020" @default.
• W3039867072 type Work @default.
• W3039867072 sameAs 3039867072 @default.
• W3039867072 citedByCount "13" @default.
• W3039867072 countsByYear W30398670722020 @default.
• W3039867072 countsByYear W30398670722021 @default.
• W3039867072 countsByYear W30398670722022 @default.
• W3039867072 crossrefType "journal-article" @default.
• W3039867072 hasAuthorship W3039867072A5006267199 @default.
• W3039867072 hasAuthorship W3039867072A5020209705 @default.
• W3039867072 hasAuthorship W3039867072A5035230144 @default.
• W3039867072 hasAuthorship W3039867072A5041530254 @default.
• W3039867072 hasAuthorship W3039867072A5056461677 @default.
• W3039867072 hasAuthorship W3039867072A5057342173 @default.
• W3039867072 hasAuthorship W3039867072A5060918113 @default.
• W3039867072 hasAuthorship W3039867072A5072624832 @default.
• W3039867072 hasAuthorship W3039867072A5078260365 @default.

• next